Corporate Narrative
Celutron Innovations was established with a singular, clear-cut imperative: to bridge the critical shortage in transplantable human tissues. Every year, thousands of patients lose their lives while on organ waiting lists. By developing advanced biomaterials and precise benchtop bioprinting hardware, we aim to make tissue fabrication accessible and routine.
Our system combines structural engineering, advanced cell biology, and clinical translation protocols. We develop patient-specific hydrogel carriers that house cell lines, allowing researchers to print structural scaffolds with extreme viability rates.
Based in Chennai, India, and incubated at the Crescent Innovation & Incubation Centre (CIIC), Celutron is supported by an interdisciplinary team of biomedical engineers, mechanical systems designers, and clinical researchers. We are focused on translating academic laboratory breakthroughs into verified medical devices.
Our Mission
“To make patient-specific tissue engineering accessible, reproducible, and clinically deployable.”
Our Vision
“A future where no patient dies waiting for a transplant.”
